These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9808483)

  • 61. Bone mineral density progression following long-term simultaneous pancreas-kidney transplantation in type-1 diabetes.
    Santos Monteiro S; Silva Santos T; Pereira CA; Duarte DB; Silva F; Martins S; Dores J
    Ann Endocrinol (Paris); 2023 Aug; 84(4):454-459. PubMed ID: 36931500
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.
    Anagnostis P; Vyzantiadis TA; Charizopoulou M; Adamidou F; Karras S; Goulis DG; Karagiannis A; Garipidou V; Vakalopoulou S
    Thromb Haemost; 2013 Aug; 110(2):257-63. PubMed ID: 23740140
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Volin L; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Ruutu T
    Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
    BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
    Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
    Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pamidronate therapy as prevention of bone loss following renal transplantation.
    Fan SL; Almond MK; Ball E; Evans K; Cunningham J
    Kidney Int; 2000 Feb; 57(2):684-90. PubMed ID: 10652047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monthly ibandronate for the prevention of bone loss in patients after liver transplantation.
    Kaemmerer D; Schmidt B; Lehmann G; Wolf G; Hommann M; Settmacher U
    Transplant Proc; 2012 Jun; 44(5):1362-7. PubMed ID: 22664016
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bone Mineral Density in Sheehan's Syndrome; Prevalence of Low Bone Mass and Associated Factors.
    Chihaoui M; Yazidi M; Chaker F; Belouidhnine M; Kanoun F; Lamine F; Ftouhi B; Sahli H; Slimane H
    J Clin Densitom; 2016 Oct; 19(4):413-418. PubMed ID: 26993664
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
    Luengo M; Pons F; Martinez de Osaba MJ; Picado C
    Thorax; 1994 Nov; 49(11):1099-102. PubMed ID: 7831624
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Maximal androgen blockade little influences bone mineral density in prostate cancer patients].
    Sun GF; Yang B; Zhu H; Li NC; Na YQ
    Zhonghua Nan Ke Xue; 2012 Nov; 18(11):978-81. PubMed ID: 23214245
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone mineral density in patients with pancreatic insufficiency and steatorrhea.
    Morán CE; Sosa EG; Martinez SM; Geldern P; Messina D; Russo A; Boerr L; Bai JC
    Am J Gastroenterol; 1997 May; 92(5):867-71. PubMed ID: 9149203
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
    Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
    J Clin Oncol; 1997 Apr; 15(4):1341-7. PubMed ID: 9193325
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bone fractures and lumbar mineral density after renal transplantation. A long-term cross-sectional study.
    Jiménez S; Marcén R; Vaamonde C; Caballero C; Fernández-Rodríguez A; Villafruela JJ; Galeano C; Teruel JL; Quereda C
    Clin Transplant; 2016 Feb; 30(2):131-7. PubMed ID: 26546290
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study.
    Rodrigues P; Hering FO; Bruna P; Meller A; Afonso Y
    Int J Urol; 2007 Apr; 14(4):317-20. PubMed ID: 17470161
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients.
    Adolphson P; Abbaszadegan H; Bodén H; Salemyr M; Henriques T
    Acta Orthop Scand; 2000 Apr; 71(2):195-200. PubMed ID: 10852328
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment.
    Floreani A; Chiaramonte M; Giannini S; Malvasi L; Lodetti MG; Castrignano R; Giacomini A; D'Angelo A; Naccarato R
    J Hepatol; 1991 Mar; 12(2):217-23. PubMed ID: 2051000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.